{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:40:31Z","timestamp":1773301231139,"version":"3.50.1"},"reference-count":127,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.intimp.2012.02.010","type":"journal-article","created":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T23:46:24Z","timestamp":1331163984000},"page":"618-625","source":"Crossref","is-referenced-by-count":36,"title":["Contribution of brain dopamine, serotonin and opioid receptors in the mechanisms of neuroimmunomodulation: Evidence from pharmacological analysis"],"prefix":"10.1016","volume":"12","author":[{"given":"Galina V.","family":"Idova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizaveta L.","family":"Alperina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita A.","family":"Cheido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2012.02.010_bb0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1025389031000111311","article-title":"Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models","volume":"6","author":"Overstreet","year":"2003","journal-title":"Stress"},{"key":"10.1016\/j.intimp.2012.02.010_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0074-7742(06)78002-3","article-title":"The dopamine system and the pathophysiology of schizophrenia: a basic science perspective","volume":"78","author":"Goto","year":"2007","journal-title":"Int Rev Neurobiol"},{"issue":"4","key":"10.1016\/j.intimp.2012.02.010_bb0015","first-page":"297","article-title":"A role of opioid receptor agonists and antagonists in the treatment of Parkinson's disease","volume":"24","author":"Silkis","year":"2007","journal-title":"Neurochemistry"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"Dunlop","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.intimp.2012.02.010_bb0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.euroneuro.2007.02.005","article-title":"Risk factors for schizophrenia \u2014 all roads lead to dopamine","volume":"17","author":"Di Forti","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.intimp.2012.02.010_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pharmthera.2008.07.006","article-title":"Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake","volume":"120","author":"Miczek","year":"2008","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.intimp.2012.02.010_bb0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00213-010-1980-y","article-title":"A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors","volume":"212","author":"Randal-Thompson","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.intimp.2012.02.010_bb0040","first-page":"63","article-title":"Selected aspects of immunological disorders in Parkinson's disease","volume":"38","author":"Fiszer","year":"2004","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.intimp.2012.02.010_bb0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/B978-012088576-3\/50030-7","article-title":"Psychoneuroimmunology of depressive disorder: mechanisms and clinical implications","volume":"1","author":"Capuron","year":"2007","journal-title":"Psychoneuroimmunology"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/157339510791823673","article-title":"Immune system and schizophrenia","volume":"3","author":"M\u00fcller","year":"2010","journal-title":"Curr Immunol Rev"},{"key":"10.1016\/j.intimp.2012.02.010_bb0055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0014-2999(68)90033-2","article-title":"Influence of some drugs on the immune response. II. Effects of serotonin, 5-hydroxytryptophan, reserpine and iproniazid on delayed hypersensitivity","volume":"4","author":"Devoino","year":"1968","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.intimp.2012.02.010_bb0060","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-2999(73)90033-2","article-title":"Influence of some drugs on the immune response. IV. Effect of serotonin, 5-hydroxytryptophan, iproniazid and p-chlorphenylalanine on the synthesis of IgM and IgG antibodies","volume":"22","author":"Devoino","year":"1973","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.intimp.2012.02.010_bb0065","first-page":"505","article-title":"Influence of serotonin on the immune response","volume":"54","author":"Jackson","year":"1985","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2012.02.010_bb0070","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1749-6632.1987.tb35805.x","article-title":"Suppression of immune response in rats by stress and drugs interfering with metabolism of serotonin","volume":"496","author":"Boranic","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.intimp.2012.02.010_bb0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/00207458808990716","article-title":"Dopaminergic stimulation of the immune reaction: interaction of serotoninergic and dopaminergic systems in neuroimmunomodulation","volume":"40","author":"Devoino","year":"1988","journal-title":"Int J Neurosci"},{"issue":"3\u20134","key":"10.1016\/j.intimp.2012.02.010_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/00207458808985733","article-title":"Participation of serotoninergic system in neuroimmunomodulation: intraimmune mechanisms and the pathways providing an inhibitory effect","volume":"40","author":"Devoino","year":"1988","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.intimp.2012.02.010_bb0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0006-8993(94)91548-2","article-title":"Brain neuromediator systems in the immune response control: pharmacological analysis of pre- and postsynaptic mechanisms","volume":"633","author":"Devoino","year":"1994","journal-title":"Brain Res"},{"issue":"3\u20134","key":"10.1016\/j.intimp.2012.02.010_bb0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/00207459708986378","article-title":"Involvement of brain dopaminergic structures in neuroimmunomodulation","volume":"91","author":"Devoino","year":"1997","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.intimp.2012.02.010_bb0095","unstructured":"Devoino LV, Idova GV, Alperina EL. Psychoneuroimmunomodulation: behavior and immunity. A role for the neuromediator pattern of the brain. Ed. \u201cNauka\u201d: Novosibirsk, 2009; Russian."},{"issue":"2","key":"10.1016\/j.intimp.2012.02.010_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/brbi.1994.1013","article-title":"Brain monoaminergic, neuroendocrine, and immune responses to an immune challenge in relation to brain and behavioral lateralization","volume":"8","author":"Delrue","year":"1994","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.intimp.2012.02.010_bb0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0960-5428(96)00018-6","article-title":"Immunoregulatory role of neurotransmitters","volume":"6","author":"Qiu","year":"1996","journal-title":"Adv Neuroimmunol"},{"issue":"2","key":"10.1016\/j.intimp.2012.02.010_bb0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-5728(99)00176-9","article-title":"Dopamine, a neurotransmitter, influences the immune system","volume":"102","author":"Basu","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2012.02.010_bb0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/brbi.2001.0625","article-title":"Role of central 5-HT2 receptors in fluoxetine-induced decreases in T lymphocyte activity","volume":"16","author":"Pellegrino","year":"2002","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.intimp.2012.02.010_bb0120","first-page":"106","article-title":"Experimental evidence for immunomodulatory effects of opioids","volume":"521","author":"Sacerdote","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.intimp.2012.02.010_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2005.11.009","article-title":"Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell","volume":"173","author":"Saurer","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.intimp.2012.02.010_bb0130","first-page":"12","article-title":"Mu-opioidergic immunomodulation: the neurochemical basis","volume":"40","author":"Cheido","year":"2009","journal-title":"Adv Physiol Sci"},{"issue":"4","key":"10.1016\/j.intimp.2012.02.010_bb0135","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bbi.2009.10.015","article-title":"The immunoregulatory role of dopamine: an update","volume":"24","author":"Sarkar","year":"2010","journal-title":"Brain Behav Immun"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2012.02.010_bb0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/00207459309000569","article-title":"Brain lateralization and immunomodulation","volume":"70","author":"Neveu","year":"1993","journal-title":"Int J Neurosci"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000097158","article-title":"Evidence for an involvement of dopamine D1 receptors in the limbic system in the control of immune mechanisms","volume":"1","author":"Nistico","year":"1994","journal-title":"Neuroimmunomodulation"},{"issue":"24","key":"10.1016\/j.intimp.2012.02.010_bb0150","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0024-3205(97)00962-4","article-title":"Effect of dopamine on immune cell proliferation in mice","volume":"61","author":"Tsao","year":"1997","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.intimp.2012.02.010_bb0155","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbi.2009.01.018","article-title":"Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in rat model of Parkinson's disease","volume":"23","author":"Engler","year":"2009","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.intimp.2012.02.010_bb0160","first-page":"1428","article-title":"A role for the hypophysis in immunomodulating influence of dopaminergic and serotoninergic systems","volume":"11","author":"Alperina","year":"1985","journal-title":"Ross Fiziol Zh Im I M Sechenova"},{"key":"10.1016\/j.intimp.2012.02.010_bb0165","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1749-6632.1987.tb35777.x","article-title":"Distribution of immunocompetent cells underlying psychoneuroimmunomodulation. Brain neuromediator control mechanisms","volume":"496","author":"Devoino","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.intimp.2012.02.010_bb0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jnr.490180113","article-title":"Modulation of T-suppressor cell activity by central nervous system catecholamine depletion","volume":"18","author":"Cross","year":"1987","journal-title":"J Neurosci Res"},{"issue":"11","key":"10.1016\/j.intimp.2012.02.010_bb0175","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0167-5699(94)90206-2","article-title":"The influence of neuroendocrine pathways on lymphocyte migration","volume":"5","author":"Ottaway","year":"1994","journal-title":"Immunol Today"},{"key":"10.1016\/j.intimp.2012.02.010_bb0180","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1080\/00207450390231437","article-title":"Evidence for a role of dopaminergic mechanisms in the immunostimulating effect of \u03bc-opioid receptor agonist DAGO","volume":"113","author":"Devoino","year":"2003","journal-title":"Int J Neurosci"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0185","first-page":"329","article-title":"Rat hippocampus and primary immune response","volume":"48","author":"Devi","year":"2004","journal-title":"Indian J Physiol Pharmacol"},{"issue":"1","key":"10.1016\/j.intimp.2012.02.010_bb0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0301-0082(02)00011-4","article-title":"Dopamine and the regulation of cognition and attention","volume":"67","author":"Nieoullon","year":"2002","journal-title":"Prog Neurobiol"},{"issue":"2","key":"10.1016\/j.intimp.2012.02.010_bb0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.brainresrev.2007.07.014","article-title":"Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective","volume":"56","author":"Alcaro","year":"2007","journal-title":"Brain Res Rev"},{"issue":"8","key":"10.1016\/j.intimp.2012.02.010_bb0200","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.psyneuen.2003.09.007","article-title":"Reduced splenic natural killer cell activity in rats with a hyperreactive dopaminergic system","volume":"29","author":"Teunis","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.intimp.2012.02.010_bb0205","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.23562","article-title":"Reduced tumor growth in a mouse model of schizophrenia, lacking the dopamine transporter","volume":"123","author":"Asada","year":"2008","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2012.02.010_bb0210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.intimp.2012.02.010_bb0215","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signalling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.intimp.2012.02.010_bb0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1227\/01.NEU.0000249209.11967.CB","article-title":"The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies","volume":"60","author":"Hodaie","year":"2007","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0225","first-page":"48","article-title":"Changes in the immune reaction of animals under conditions of drug-induced activation and blockade of D1 dopamine receptors","volume":"67","author":"Devoino","year":"2004","journal-title":"Exp Clin Pharmacol"},{"key":"10.1016\/j.intimp.2012.02.010_bb0230","first-page":"93","article-title":"Alterations of immune reactivity by haloperidol and delta-9-tetrahydrocannadinol","volume":"3","author":"Levy","year":"1981","journal-title":"J Immunol"},{"issue":"9\u201310","key":"10.1016\/j.intimp.2012.02.010_bb0235","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0192-0561(97)00077-5","article-title":"Modulation of the immune response by changing neuromediator systems activity under stress","volume":"19","author":"Idova","year":"1997","journal-title":"Int J Immunopharmacol"},{"issue":"2","key":"10.1016\/j.intimp.2012.02.010_bb0240","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11055-007-0162-9","article-title":"Involvement of dopamine D1 and D2 receptors in the rat nucleus accumbens in immunostimulation","volume":"37","author":"Devoino","year":"2007","journal-title":"Neurosci Behav Physiol"},{"issue":"4","key":"10.1016\/j.intimp.2012.02.010_bb0245","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/14728222.10.4.515","article-title":"Targeting the dopamine D2 receptor in schizophrenia","volume":"10","author":"Seeman","year":"2006","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"10.1016\/j.intimp.2012.02.010_bb0250","first-page":"2","article-title":"Functional interplay of dopamine D1 and D2 receptors in the immune response control in different psychoemotional states","volume":"73","author":"Alperina","year":"2010","journal-title":"Exp Clin Pharmacol"},{"key":"10.1016\/j.intimp.2012.02.010_bb0255","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/brbi.1993.1009","article-title":"Immune responses in male mice with aggressive and submissive behavior patterns: strain differences","volume":"7","author":"Devoino","year":"1993","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.intimp.2012.02.010_bb0260","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0889-1591(02)00037-5","article-title":"Immunological consequences of the reversal of social status in C57BL\/6J mice","volume":"17","author":"Devoino","year":"2003","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.intimp.2012.02.010_bb0265","first-page":"173","article-title":"Behavioral genetics and immunity","volume":"2","author":"Petitto","year":"2001","journal-title":"Psychoneuroimmunology"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0270","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0031-9384(01)00495-4","article-title":"Social stress in laboratory rats: behavior, immune function, and tumor metastasis","volume":"73","author":"Stefanski","year":"2001","journal-title":"Physiol Behav"},{"issue":"5","key":"10.1016\/j.intimp.2012.02.010_bb0275","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bbi.2003.11.007","article-title":"The rank assessed in a food competition test influences subsequent reactivity to immune and social challenges in mice","volume":"18","author":"Merlot","year":"2004","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0280","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0031-9384(01)00449-8","article-title":"Animal models of social stress: effects on behavior and brain neurochemical system","volume":"73","author":"Blanchard","year":"2001","journal-title":"Physiol Behav"},{"key":"10.1016\/j.intimp.2012.02.010_bb0285","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/00207450490450172","article-title":"Regional changes of brain serotonin and its metabolite 5-hydroxyindolacetic acid and development of immunosuppression in submissive mice","volume":"114","author":"Devoino","year":"2004","journal-title":"Int J Neurosci"},{"issue":"1","key":"10.1016\/j.intimp.2012.02.010_bb0290","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuroscience.2010.04.044","article-title":"Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydrohy-2(di-n-propylamino)tetralin treatment on the expression of key genes in brain serotonin system and on behavior","volume":"169","author":"Popova","year":"2010","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.intimp.2012.02.010_bb0295","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s11055-007-0074-8","article-title":"Effects of activation and blockade of dopamine D(2) receptors on the immune response in mice with different types of behavior","volume":"37","author":"Idova","year":"2007","journal-title":"Neurosci Behav Physiol"},{"key":"10.1016\/j.intimp.2012.02.010_bb0300","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/00207459608987265","article-title":"Involvement of delta-opioid receptors in immunosuppression","volume":"84","author":"Cheido","year":"1996","journal-title":"Int J Neurosci"},{"issue":"2","key":"10.1016\/j.intimp.2012.02.010_bb0305","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotoninergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.intimp.2012.02.010_bb0310","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1755-5949.2010.00135.x","article-title":"Role of serotonin in central dopamine dysfunction","volume":"16","author":"Di Giovanni","year":"2010","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"10.1016\/j.intimp.2012.02.010_bb0315","first-page":"266","article-title":"Studies on the neuroendocrine role of serotonin","volume":"54","author":"J\u00f8rgensen","year":"2007","journal-title":"Dan Med Bull"},{"issue":"1","key":"10.1016\/j.intimp.2012.02.010_bb0320","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbr.2008.06.011","article-title":"Molecular imaging of the 5-HT(1A) receptor in relation to human cognition","volume":"195","author":"Borg","year":"2008","journal-title":"Behav Brain Res"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0620","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.neuroimage.2010.12.060","article-title":"Chronic stress is linked to 5-HT1A receptor changes and functional disintegration of the limbic networks","volume":"55","author":"Jovanic","year":"2011","journal-title":"Neuroimage"},{"issue":"7","key":"10.1016\/j.intimp.2012.02.010_bb0625","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.intimp.2012.02.010_bb0630","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.physbeh.2011.02.033","article-title":"Effects of dominance status on conditioned defeat and expression of 5-HT1A and 5-HT2A receptors","volume":"104","author":"Morrison","year":"2011","journal-title":"Physiol Behav"},{"issue":"6","key":"10.1016\/j.intimp.2012.02.010_bb0330","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jpsychires.2007.05.004","article-title":"Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides","volume":"42","author":"Boldrini","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.intimp.2012.02.010_bb0335","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT1A receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.intimp.2012.02.010_bb0635","first-page":"252","article-title":"The therapeutic role of 5-HT1A and 5-HT2A receptors in depression","volume":"29","author":"Celada","year":"2004","journal-title":"J Psychiatry Neurosci"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0640","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.pnpbp.2005.11.008","article-title":"Serotonin 1A and 2A receptor densities, neurochemical and behavioural characteristics in two closely related mice strains after long-term isolation","volume":"30","author":"Schiller","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.intimp.2012.02.010_bb0345","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","article-title":"5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation a possible mechanism of atypical antipsychotic-induced cortical dopamine release","volume":"76","author":"Ichikawa","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.intimp.2012.02.010_bb0645","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0079-6123(08)00908-4","article-title":"Role of serotonin and dopamine receptor binding in antipsychotic efficacy","volume":"72","author":"Richtand","year":"2008","journal-title":"Prog Brain Res"},{"issue":"6","key":"10.1016\/j.intimp.2012.02.010_bb0650","first-page":"1","article-title":"Pharmacogenetics of antidepressants","volume":"2","author":"Crisafulli","year":"2011","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.intimp.2012.02.010_bb0355","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/brbi.1998.0532","article-title":"Role of serotonin in the immune system and in neuroimmune interactions","volume":"12","author":"Mossner","year":"1998","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.intimp.2012.02.010_bb0360","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coph.2011.02.004","article-title":"5-HT and the immune system","volume":"11","author":"Ahern","year":"2011","journal-title":"Curr Opin Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2012.02.010_bb0365","first-page":"359","article-title":"5-HT agonist-induced changes in peripheral immune cells in healthy volunteers: the impact of personality","volume":"73","author":"Hennig","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.intimp.2012.02.010_bb0370","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1080\/00207450701768887","article-title":"Serotoninergic mechanisms of immunomodulation under different psychoemotional states: I. A role of 5-HT1A receptor subtype","volume":"118","author":"Idova","year":"2008","journal-title":"Int J Neurosci"},{"issue":"10","key":"10.1016\/j.intimp.2012.02.010_bb0375","first-page":"1156","article-title":"Presynaptic 5-HT1A receptors in immunomodulation","volume":"3","author":"Davydova","year":"2007","journal-title":"Ross Fiziol Zh Im I M Sechenova"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0380","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-2999(88)90205-1","article-title":"The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice","volume":"154","author":"Yamada","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.intimp.2012.02.010_bb0385","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0166-4328(96)00118-0","article-title":"Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent selective and silent 5-HT1A receptor antagonist","volume":"73","author":"Fletcher","year":"1996","journal-title":"Behav Brain Res"},{"issue":"5","key":"10.1016\/j.intimp.2012.02.010_bb0390","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11055-010-9287-3","article-title":"Involvement of presynaptic 5-HT1A receptors in immunomodulation in conditions of psychoemotional tension","volume":"40","author":"Idova","year":"2010","journal-title":"Neurosci Behav Physiol"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0395","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10517-011-1329-5","article-title":"Immune response in C57BL\/6J mice at different stages of depressive-like behavior under activation of pre- and postsynaptic receptors","volume":"151","author":"Idova","year":"2011","journal-title":"Bull Exp Biol Med"},{"issue":"2","key":"10.1016\/j.intimp.2012.02.010_bb0400","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10517-010-1109-7","article-title":"Effects of 5-HT2A receptor stimulation and blocking on immune response","volume":"150","author":"Davydova","year":"2010","journal-title":"Bull Exp Biol Med"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0405","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0031-6997(24)01417-0","article-title":"Autoregulation of serotonin neurons: role in antidepressant drug action","volume":"51","author":"Pineyro","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.intimp.2012.02.010_bb0410","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/BF00842479","article-title":"Stimulation of the immune response during blockade of serotonin receptors by cyproheptadine","volume":"103","author":"Idova","year":"1987","journal-title":"Bull Exp Biol Med"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0415","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cercor\/bhg128","article-title":"Co-expression and in vivo interaction of serotonin 1A and serotonin 2A receptors in pyramidal neurons of prefrontal cortex","volume":"14","author":"Amargos-Bosch","year":"2004","journal-title":"Cereb Cortex"},{"issue":"5","key":"10.1016\/j.intimp.2012.02.010_bb0420","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0893-133X(98)00037-2","article-title":"Effect of chronic serotonin-2 receptor agonist or antagonist administration on serotonin-1A receptor sensitivity","volume":"19","author":"Hensler","year":"1998","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0425","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1124\/jpet.106.116004","article-title":"Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo","volume":"320","author":"Carrasco","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0430","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.pbb.2007.09.011","article-title":"The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component","volume":"88","author":"Reissig","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.intimp.2012.02.010_bb0435","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0163-7258(94)00075-E","article-title":"Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans?","volume":"66","author":"Berendsen","year":"1995","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.intimp.2012.02.010_bb0440","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0893-133X(96)00053-X","article-title":"5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia","volume":"15","author":"Burnet","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.intimp.2012.02.010_bb0445","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/jpet.103.062224","article-title":"Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo","volume":"310","author":"Zhang","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"13","key":"10.1016\/j.intimp.2012.02.010_bb0450","first-page":"481","article-title":"Role of delta-opioid receptors in biological processes","volume":"13","author":"Coop","year":"2000","journal-title":"Drug News Perspect"},{"issue":"1","key":"10.1016\/j.intimp.2012.02.010_bb0455","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0022-3565(24)34884-0","article-title":"Effect of chronic social stress on delta-opioid receptor function in the rat","volume":"290","author":"Pohorecky","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.intimp.2012.02.010_bb0460","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/brain\/awm255","article-title":"Imaging of opioid receptors in the central nervous system","volume":"131","author":"Henriksen","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2012.02.010_bb0465","first-page":"291","article-title":"The serotonin-dependent suppression of the immune response by kappa-opiate receptors","volume":"9","author":"Cheido","year":"1993","journal-title":"Bull Exp Biol Med"},{"issue":"4","key":"10.1016\/j.intimp.2012.02.010_bb0470","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0143-4179(98)90052-X","article-title":"Immunomodulatory action of class mu-, delta- and kappa-opioid receptor agonists in mice","volume":"32","author":"Kowalski","year":"1998","journal-title":"Neuropeptides"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0475","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0162-3109(00)00213-7","article-title":"Modulation of humoral immune responses in the rat by centrally applied Met-Enk and opioid receptor antagonists: functional interactions of brain OP1, OP2 and OP3 receptors","volume":"49","author":"Dimitrijevic","year":"2000","journal-title":"Immunopharmacology"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0480","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/brbi.1999.0575","article-title":"Involvement of central \u03bc- but not \u03b4- or \u03ba-opioid receptors in immunomodulation","volume":"14","author":"Nelson","year":"2000","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.intimp.2012.02.010_bb0485","first-page":"248","article-title":"Peculiarities of the distribution of cellular subpopulations in the spleen and peripheral blood of CBA mice under conditions of activation of the mu- and delta-opioid systems","volume":"5","author":"Cheido","year":"2011","journal-title":"Immunology"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2012.02.010_bb0490","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0165-5728(02)00419-8","article-title":"Enhanced humoral response in kappa-opioid receptor knockout mice","volume":"134","author":"Gaveriaux-Ruff","year":"2003","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.intimp.2012.02.010_bb0495","first-page":"385","article-title":"Effect of opioid peptides on immunomodulation","volume":"84","author":"Cheido","year":"1998","journal-title":"Ross Fiziol Zh Im I M Sechenova"},{"issue":"8","key":"10.1016\/j.intimp.2012.02.010_bb0500","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.neuropharm.2004.02.003","article-title":"Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats","volume":"46","author":"Matsuzaki","year":"2004","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.intimp.2012.02.010_bb0505","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11055-009-9169-8","article-title":"The contribution of serotonin 1A receptors to kappa opioid immunosuppression","volume":"39","author":"Cheido","year":"2009","journal-title":"Neurosci Behav Physiol"},{"issue":"12","key":"10.1016\/j.intimp.2012.02.010_bb0510","first-page":"1234","article-title":"Role of serotonin receptors in the delta-opioid immunosuppression","volume":"96","author":"Cheido","year":"2010","journal-title":"Ross Fiziol Zh Im I M Sechenova"},{"issue":"5","key":"10.1016\/j.intimp.2012.02.010_bb0515","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0197-0186(94)90089-2","article-title":"\u03bc-, \u03b4-, \u03ba-Opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments","volume":"24","author":"Fowler","year":"1994","journal-title":"Neurochem Int"},{"issue":"6","key":"10.1016\/j.intimp.2012.02.010_bb0520","first-page":"28","article-title":"Mu opiate receptor subtypes","volume":"10","author":"Cadet","year":"2004","journal-title":"Med Sci Monit"},{"issue":"3","key":"10.1016\/j.intimp.2012.02.010_bb0525","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0022-3565(24)39167-0","article-title":"Interaction of p-fluorofentanyl on cloned human opioid receptors and exploration of the role of Trp-318 and His-319 in \u03bc-opioid receptor selectivity","volume":"294","author":"Ulens","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.intimp.2012.02.010_bb0530","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1073\/pnas.88.2.360","article-title":"Immunomodulatory activity of mu- and kappa-selective opioid agonists","volume":"88","author":"Taub","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2012.02.010_bb0535","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1025125828192","article-title":"Effect of beta-endorphin and DAGO, a selective agonist of mu-opioid receptors, on the proliferative activity of lymphocytes","volume":"391","author":"Gein","year":"2003","journal-title":"Dokl Biol Sci"},{"issue":"2","key":"10.1016\/j.intimp.2012.02.010_bb0540","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-3565(25)39466-8","article-title":"Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids","volume":"267","author":"Szabo","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"10.1016\/j.intimp.2012.02.010_bb0545","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.peptides.2004.05.005","article-title":"Modulation of anxiety-related behaviors by mu- and kappa-opioid receptor agonists depends on the social status of mice","volume":"25","author":"Kudryavtseva","year":"2004","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.intimp.2012.02.010_bb0550","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/syn.10078","article-title":"Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man","volume":"45","author":"Hagelberg","year":"2002","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.intimp.2012.02.010_bb0555","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ar.a.20054","article-title":"Ultrastructural evidence for co-localization of dopamine D2 and \u03bc-opioid receptors in the rat dorsolateral striatum","volume":"279A","author":"Ambrose","year":"2004","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"issue":"7","key":"10.1016\/j.intimp.2012.02.010_bb0560","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s11055-007-0073-9","article-title":"The differential contribution of dopamine D(1) and D(2) receptors to mu-opioidergic immunomodulation","volume":"37","author":"Cheido","year":"2007","journal-title":"Neurosci Behav Physiol"},{"key":"10.1016\/j.intimp.2012.02.010_bb0565","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0014-2999(91)90450-5","article-title":"Evidence for two subtypes of \u03b4 opioid receptors in rat brain","volume":"196","author":"Negri","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"14","key":"10.1016\/j.intimp.2012.02.010_bb0570","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0024-3205(01)00962-6","article-title":"Ligand binding profiles of delta-opioid receptor in human cerebral cortex membranes: evidence of delta-opioid receptor heterogeneity","volume":"68","author":"Kim","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.intimp.2012.02.010_bb0575","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0196-9781(95)02051-9","article-title":"A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides","volume":"17","author":"House","year":"1996","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.intimp.2012.02.010_bb0580","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/BF02360170","article-title":"Participation of opiate delta-receptors in immunomodulation","volume":"24","author":"Cheido","year":"1994","journal-title":"Neurosci Behav Physiol"},{"issue":"11","key":"10.1016\/j.intimp.2012.02.010_bb0585","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S1567-5769(01)00128-X","article-title":"Administration of mu-, kappa- or delta2-receptor agonists via osmotic minipumps suppresses murine splenic antibody responses","volume":"1","author":"Rahim","year":"2001","journal-title":"Int J Immunopharmacol"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2012.02.010_bb0590","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneuroim.2004.04.006","article-title":"The delta-opioid receptor participates in T-cell development by promoting negative selection","volume":"153","author":"McCarthy","year":"2004","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.intimp.2012.02.010_bb0595","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0162-3109(90)90043-E","article-title":"Stimulation of human peripheral lymphocytes by methionine enkephalin and delta-selective opioid analogues","volume":"19","author":"Hucklebridge","year":"1990","journal-title":"Immunopharmacology"},{"issue":"5","key":"10.1016\/j.intimp.2012.02.010_bb0600","first-page":"505","article-title":"DSLET and ACTH4\u201310 increase mitotic activity of hepatocytes and suppress antibody production","volume":"135","author":"Smakhtin","year":"2004","journal-title":"Bull Exp Biol Med"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2012.02.010_bb0605","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0006-8993(94)91196-7","article-title":"Opposing activities of brain opioid receptors in the regulation of humoral and cell-mediated immune responses in the rat","volume":"661","author":"Radulovic","year":"1994","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.intimp.2012.02.010_bb0610","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-5728(95)00171-9","article-title":"Regulation of human B lymphocyte activation by opioid peptide hormones. Inhibition of IgG production by opioid receptor class (mu-, kappa-, and delta) selective agonists","volume":"65","author":"Morgan","year":"1996","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.intimp.2012.02.010_bb0615","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s10517-010-0843-1","article-title":"Immune response of submissive and aggressive mice under conditions of opioid receptor activation","volume":"148","author":"Cheido","year":"2009","journal-title":"Bull Exp Biol Med"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576912000628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576912000628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T16:28:06Z","timestamp":1742660886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576912000628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":127,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1567576912000628"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2012.02.010","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}